2020 Q4 Form 10-K Financial Statement

#000162828021004184 Filed on March 09, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 2019 Q4
Revenue $135.0M $47.02M $42.59M
YoY Change 217.04% 156.13% 1.89%
Cost Of Revenue $34.90M $118.9M $31.05M
YoY Change 12.4% -11.78% -15.81%
Gross Profit $16.17M $1.041M $11.54M
YoY Change 40.14% 10.21% 134.55%
Gross Profit Margin 11.98% 2.21% 27.1%
Selling, General & Admin $26.14M $8.117M $6.650M
YoY Change 293.15% 21.93% 26.43%
% of Gross Profit 161.66% 779.94% 57.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.850M $529.9K $1.850M
YoY Change 0.0% 14.93% 5.11%
% of Gross Profit 11.44% 50.92% 16.03%
Operating Expenses $26.14M $8.189M $8.490M
YoY Change 207.94% 23.01% 21.11%
Operating Profit -$11.87M -$7.148M $3.050M
YoY Change -489.11% 25.13% -245.93%
Interest Expense -$450.0K $409.8K -$1.570M
YoY Change -71.34% -24.28% -176.59%
% of Operating Profit -51.48%
Other Income/Expense, Net $1.105M
YoY Change -704.61%
Pretax Income -$2.940M -$6.044M $1.370M
YoY Change -314.6% 2.52% -3525.0%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$3.390M -$12.04M $1.430M
YoY Change -337.06% 138.41% -815.0%
Net Earnings / Revenue -2.51% -25.6% 3.36%
Basic Earnings Per Share -$0.67
Diluted Earnings Per Share -$74.41K -$0.67 $33.98K
COMMON SHARES
Basic Shares Outstanding 45.55M shares 45.51M shares 41.85M shares
Diluted Shares Outstanding 45.51M shares

Balance Sheet

Concept 2020 Q4 2020 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.90M $10.90M $4.100M
YoY Change 165.85% 165.85% 215.38%
Cash & Equivalents $10.90M $10.90M $4.100M
Short-Term Investments
Other Short-Term Assets $3.300M $3.300M $4.600M
YoY Change -28.26% -28.26% -6.12%
Inventory $1.458M $4.400M $6.547M
Prepaid Expenses $2.589M $4.453M
Receivables $5.212M $11.10M $12.14M
Other Receivables $0.00 $0.00 $100.0K
Total Short-Term Assets $29.79M $29.80M $27.41M
YoY Change 8.68% 8.76% 16.41%
LONG-TERM ASSETS
Property, Plant & Equipment $13.28M $81.30M $44.76M
YoY Change -70.34% 0.12% -4.53%
Goodwill
YoY Change
Intangibles $11.24M
YoY Change -10.61%
Long-Term Investments
YoY Change
Other Assets $1.009M $1.600M $840.8K
YoY Change 19.98% 100.0% 36.32%
Total Long-Term Assets $92.31M $92.30M $93.35M
YoY Change -1.11% -1.18% 54.0%
TOTAL ASSETS
Total Short-Term Assets $29.79M $29.80M $27.41M
Total Long-Term Assets $92.31M $92.30M $93.35M
Total Assets $122.1M $122.1M $120.8M
YoY Change 1.11% 1.08% 43.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.311M $10.50M $7.620M
YoY Change -56.55% 38.16% -13.32%
Accrued Expenses $1.649M $7.700M $5.016M
YoY Change -67.13% -29.36% 97.85%
Deferred Revenue
YoY Change
Short-Term Debt $100.0K $100.0K $3.276M
YoY Change -96.95% -96.97% -14.78%
Long-Term Debt Due $6.712M $4.900M $2.017M
YoY Change 232.7% 122.73% 52.22%
Total Short-Term Liabilities $26.19M $23.90M $24.80M
YoY Change 5.64% -3.63% 45.9%
LONG-TERM LIABILITIES
Long-Term Debt $5.637M $8.900M $12.43M
YoY Change -54.66% -31.54% -13.67%
Other Long-Term Liabilities $28.00M $28.00M $31.70M
YoY Change -11.67% -11.67% 2013.33%
Total Long-Term Liabilities $5.637M $36.90M $12.43M
YoY Change -54.66% -17.45% -13.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.19M $23.90M $24.80M
Total Long-Term Liabilities $5.637M $36.90M $12.43M
Total Liabilities $60.81M $93.70M $69.51M
YoY Change -12.52% 25.44% 109.55%
SHAREHOLDERS EQUITY
Retained Earnings -$90.01M -$59.25M
YoY Change 51.92% 23.94%
Common Stock $45.56K $43.40K
YoY Change 4.98% 8.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.607M $28.40M $22.32M
YoY Change
Total Liabilities & Shareholders Equity $122.1M $122.1M $120.8M
YoY Change 1.11% 1.08% 43.49%

Cashflow Statement

Concept 2020 Q4 2020 2019 Q4
OPERATING ACTIVITIES
Net Income -$3.390M -$12.04M $1.430M
YoY Change -337.06% 138.41% -815.0%
Depreciation, Depletion And Amortization $1.850M $529.9K $1.850M
YoY Change 0.0% 14.93% 5.11%
Cash From Operating Activities -$1.430M -$76.40K $5.530M
YoY Change -125.86% -103.09% 11.27%
INVESTING ACTIVITIES
Capital Expenditures -$2.470M $937.3K -$570.0K
YoY Change 333.33% 336.05% -17.39%
Acquisitions $1.823M
YoY Change
Other Investing Activities $40.00K -$1.750M $140.0K
YoY Change -71.43% -860.87% -1500.0%
Cash From Investing Activities -$2.420M -$8.433M -$430.0K
YoY Change 462.79% 132.55% -37.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -800.0K $15.31M -3.310M
YoY Change -75.83% 511.41% 1.53%
NET CHANGE
Cash From Operating Activities -1.430M -$76.40K 5.530M
Cash From Investing Activities -2.420M -$8.433M -430.0K
Cash From Financing Activities -800.0K $15.31M -3.310M
Net Change In Cash -4.650M $6.795M 1.790M
YoY Change -359.78% 403.36% 75.49%
FREE CASH FLOW
Cash From Operating Activities -$1.430M -$76.40K $5.530M
Capital Expenditures -$2.470M $937.3K -$570.0K
Free Cash Flow $1.040M -$1.014M $6.100M
YoY Change -82.95% -144.89% 7.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0000890447
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
001-11476
CY2020 dei Entity Registrant Name
EntityRegistrantName
VERTEX ENERGY, INC.
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3439569
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
1331 Gemini Street
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 250
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77058
CY2020 dei City Area Code
CityAreaCode
866
CY2020 dei Local Phone Number
LocalPhoneNumber
660-8156
CY2020 dei Security12b Title
Security12bTitle
Common Stock,$0.001 Par Value Per Share
CY2020 dei Trading Symbol
TradingSymbol
VTNR
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
26644057 USD
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49888947 shares
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10895044 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4099655 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100125 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100170 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11138933 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12138078 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 USD
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
68606 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
4439839 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
6547479 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3211448 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4452920 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
29785389 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
27406908 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
75777552 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
69469548 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29337036 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24708151 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46440516 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44761397 USD
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1536711 USD
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
851570 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33315876 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
35586885 USD
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
9397441 USD
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
11243800 USD
CY2020Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
0 USD
CY2019Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
68605 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1624025 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
840754 USD
CY2020Q4 us-gaap Assets
Assets
122099958 USD
CY2019Q4 us-gaap Assets
Assets
120759919 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10484911 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7620098 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2053106 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5016132 USD
CY2020Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
606550 USD
CY2019Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
389176 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
496231 USD
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
217164 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5614785 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5885304 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4367169 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2017345 USD
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
133446 USD
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3276230 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
94214 USD
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
375850 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23850412 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24797299 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7981496 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12433000 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
945612 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
610450 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27701091 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29701581 USD
CY2020Q4 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
330412 USD
CY2019Q4 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
1969216 USD
CY2020Q4 us-gaap Liabilities
Liabilities
60809023 USD
CY2019Q4 us-gaap Liabilities
Liabilities
69511546 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
31611674 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
4396894 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
55366186 USD
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
28146347 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45554841 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45554841 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43395563 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43395563 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
45555 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
43396 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
94569674 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
81527351 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90008778 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59246514 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4606871 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
22324653 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
1317878 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
777373 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5924749 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23102026 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
122099958 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
120759919 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
135028488 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163365565 USD
CY2020 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
113766009 USD
CY2019 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
134777113 USD
CY2020 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
5090352 USD
CY2019 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
5356277 USD
CY2020 us-gaap Gross Profit
GrossProfit
16172127 USD
CY2019 us-gaap Gross Profit
GrossProfit
23232175 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26144264 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24182407 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1895588 USD
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1823812 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
28039852 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
26006219 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-11867725 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-2774044 USD
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
101 USD
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
920197 USD
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-124515 USD
CY2019 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-74111 USD
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1638804 USD
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
487524 USD
CY2020 us-gaap Interest Expense
InterestExpense
1042840 USD
CY2019 us-gaap Interest Expense
InterestExpense
3070071 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
471550 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2711509 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11396175 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5485553 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-11396175 USD
CY2019 us-gaap Profit Loss
ProfitLoss
-5485553 USD
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
639940 USD
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-436974 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-12036115 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-5048579 USD
CY2020 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
15135242 USD
CY2019 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2279371 USD
CY2020 vtnr Preferred Stock Accretion Of Discount
PreferredStockAccretionOfDiscount
1687850 USD
CY2019 vtnr Preferred Stock Accretion Of Discount
PreferredStockAccretionOfDiscount
2489722 USD
CY2020 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
1903057 USD
CY2019 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
1627956 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30762264 USD
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11445628 USD
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45509470 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40988946 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45509470 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40988946 shares
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28809044 USD
CY2019 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
285534 USD
CY2019 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1627956 USD
CY2019 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
2489722 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
642840 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7075 USD
CY2019 vtnr Conversionof Preferred C Stockto Common Value
ConversionofPreferredCStocktoCommonValue
970809 USD
CY2019 vtnr Conversionof Preferred B1 Stockto Common Value
ConversionofPreferredB1StocktoCommonValue
2562015 USD
CY2019 us-gaap Increase In Carrying Amount Of Redeemable Preferred Stock
IncreaseInCarryingAmountOfRedeemablePreferredStock
2279371 USD
CY2019 vtnr Stock And Warrants Issued During Period Value Common Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValueCommonStockAndWarrants
2216711 USD
CY2019 us-gaap Profit Loss
ProfitLoss
-5485553 USD
CY2019 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-61668 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23102026 USD
CY2020 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1903057 USD
CY2020 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
1687850 USD
CY2020 vtnr Conversionof Preferred B1 Stockto Common Value
ConversionofPreferredB1StocktoCommonValue
3368474 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
656111 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-71171 USD
CY2020 us-gaap Increase In Carrying Amount Of Redeemable Preferred Stock
IncreaseInCarryingAmountOfRedeemablePreferredStock
15135242 USD
CY2020 vtnr Conversionof Preferred C Stockto Common Value
ConversionofPreferredCStocktoCommonValue
9091068 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-11396175 USD
CY2020 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
99435 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5924749 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-11396175 USD
CY2019 us-gaap Profit Loss
ProfitLoss
-5485553 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
656111 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
642840 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6985940 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7180089 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
297289 USD
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-320013 USD
CY2020 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
3456487 USD
CY2019 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
-2458359 USD
CY2020 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-4233092 USD
CY2019 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
2841052 USD
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-124515 USD
CY2019 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-74111 USD
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
47826 USD
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
573908 USD
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1638804 USD
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
487524 USD
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-15564 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2641220 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2652864 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3084152 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1543918 USD
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-197715 USD
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
257894 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1840874 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1171433 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3047606 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2480786 USD
CY2020 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
646059 USD
CY2019 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
223995 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76397 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2473167 USD
CY2020 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
49229 USD
CY2019 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
489093 USD
CY2020 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
74965 USD
CY2019 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
232020 USD
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1822690 USD
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6636455 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3369367 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8433409 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3626440 USD
CY2020 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-3142784 USD
CY2019 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-568406 USD
CY2020 vtnr Proceeds From Issuance Of Common Stock And Warrant Exercises
ProceedsFromIssuanceOfCommonStockAndWarrantExercises
0 USD
CY2019 vtnr Proceeds From Issuance Of Common Stock And Warrant Exercises
ProceedsFromIssuanceOfCommonStockAndWarrantExercises
2216711 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7075 USD
CY2020 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2019 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
285534 USD
CY2020 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
21000000 USD
CY2019 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
3150000 USD
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
402560 USD
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
165598 USD
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
8217195 USD
CY2019 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2809139 USD
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
10366701 USD
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4660120 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15305150 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2503267 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6795344 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1349994 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4199825 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4199825 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2849831 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10995169 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1050741 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
2505852 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1903057 USD
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1627956 USD
CY2020 vtnr Noncontrolling Interest Adjustment To Carrying Amount
NoncontrollingInterestAdjustmentToCarryingAmount
9091068 USD
CY2019 vtnr Noncontrolling Interest Adjustment To Carrying Amount
NoncontrollingInterestAdjustmentToCarryingAmount
970809 USD
CY2020 vtnr Preferred Stock Accretion Of Discount
PreferredStockAccretionOfDiscount
1687850 USD
CY2019 vtnr Preferred Stock Accretion Of Discount
PreferredStockAccretionOfDiscount
2489722 USD
CY2020 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
15135242 USD
CY2019 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2279371 USD
CY2020 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1017638 USD
CY2019 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
621000 USD
CY2020Q4 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
15 state
CY2020Q4 vtnr Working Capital
WorkingCapital
5934977 USD
CY2019Q4 vtnr Working Capital
WorkingCapital
2609609 USD
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10895044 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4099655 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100125 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100170 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10995169 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4199825 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
612746 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
402475 USD
CY2020 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Reclassification of Prior Year PresentationCertain prior period amounts have been reclassified to conform to current period presentation. These reclassifications had no effect on the reported results of operations, stockholders' equity or cash flows.
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates. Any effects on the business, financial position or results of operations from revisions to these estimates are recorded in the period in which the facts that give rise to the revision become known.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant items subject to estimates and assumptions include the carrying amount and useful lives of property and equipment and intangible assets, impairment assessments, share-based compensation expense, and valuation allowances for accounts receivable, inventories, deferred tax assets, and redemption value of noncontrolling interest.</span></div>
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163365565 USD
CY2020 us-gaap Depreciation
Depreciation
4757855 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
135028488 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
135028488 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163365565 USD
CY2020 vtnr Numberof Independent Directorsin Related Party Committee
NumberofIndependentDirectorsinRelatedPartyCommittee
2 independent_director
CY2020 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
62185 USD
CY2019 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
100683 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
75777552 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
69469548 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29337036 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24708151 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46440516 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44761397 USD
CY2019 us-gaap Depreciation
Depreciation
5189331 USD
CY2020 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
71171 USD
CY2019 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
0 USD
CY2020 vtnr Adjustments To Retained Earnings Reclassification From Noncontrolling Interests
AdjustmentsToRetainedEarningsReclassificationFromNoncontrollingInterests
9091068 USD
CY2020 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
21000000 USD
CY2020 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
192538120 USD
CY2019 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
261669500 USD
CY2020 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-11881125 USD
CY2019 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-5724176 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23255887 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13858446 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9397441 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23206658 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11962858 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11243800 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1895588 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1823812 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1895588 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1680660 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1323276 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1266833 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1078630 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2152454 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9397441 USD
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
11751679 USD
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
12540553 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
612746 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
402475 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11138933 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12138078 USD
CY2020 vtnr Lineof Credit Debt Covenant Eventof Default Period During Whicha Majorityof Duly Elected Board Members Ceaseto Serve
LineofCreditDebtCovenantEventofDefaultPeriodDuringWhichaMajorityofDulyElectedBoardMembersCeasetoServe
P12M
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
13923954 USD
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18602017 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
0 USD
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
47826 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
13923954 USD
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
18554191 USD
CY2020Q4 vtnr Longterm Debtand Finance Lease Liability Year One
LongtermDebtandFinanceLeaseLiabilityYearOne
4996846 USD
CY2020Q4 vtnr Longterm Debtand Finance Lease Liability Due Year Two
LongtermDebtandFinanceLeaseLiabilityDueYearTwo
8425698 USD
CY2020Q4 vtnr Long Term Debt And Finance Lease Liability Due Year Three
LongTermDebtAndFinanceLeaseLiabilityDueYearThree
429522 USD
CY2020Q4 vtnr Longterm Debtand Finance Lease Liability Due Year Four
LongtermDebtandFinanceLeaseLiabilityDueYearFour
71888 USD
CY2020Q4 vtnr Longterm Debtand Finance Lease Liability Due Year Five
LongtermDebtandFinanceLeaseLiabilityDueYearFive
0 USD
CY2020Q4 vtnr Longterm Debtand Finance Lease Liability Due After Year Five
LongtermDebtandFinanceLeaseLiabilityDueAfterYearFive
0 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
69000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
68606 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-69000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-68606 USD
CY2020 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2019 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2393000 USD
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1152000 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
7000 USD
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
139000 USD
CY2020 vtnr Effective Income Tax Rate Reconciliation Change In Derivative Liability Amount
EffectiveIncomeTaxRateReconciliationChangeInDerivativeLiabilityAmount
-344000 USD
CY2019 vtnr Effective Income Tax Rate Reconciliation Change In Derivative Liability Amount
EffectiveIncomeTaxRateReconciliationChangeInDerivativeLiabilityAmount
102000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1745000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
210000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
904000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1344000 USD
CY2020 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
81000 USD
CY2019 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-643000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
0 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
69000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
403000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
386000 USD
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1406000 USD
CY2020Q4 vtnr Deferred Tax Assets Disallowed Interest Expense
DeferredTaxAssetsDisallowedInterestExpense
0 USD
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1687000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
120000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
85000 USD
CY2020Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
41000 USD
CY2019Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
38000 USD
CY2019Q4 vtnr Deferred Tax Assets Disallowed Interest Expense
DeferredTaxAssetsDisallowedInterestExpense
487000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15168000 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
13682000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14357000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13453000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2781000 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2981000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2163000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2788000 USD
CY2020Q4 vtnr Deferred Tax Liabilities Contingent Liability
DeferredTaxLiabilitiesContingentLiability
0 USD
CY2019Q4 vtnr Deferred Tax Liabilities Contingent Liability
DeferredTaxLiabilitiesContingentLiability
0 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Investment In Noncontrolled Affiliates
DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
618000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Investment In Noncontrolled Affiliates
DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
124000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2781000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2912000 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
69000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14357000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13453000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
656111 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
642840 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3460750 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.05
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3469298 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1150000 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.40
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P8Y9M3D
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
1148662 USD
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
112500 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.46
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
41789 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
80000 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.46
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodFairValue
28800 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4418250 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.95
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4547371 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2383625 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.50
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y10M2D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.50
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y10M2D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2625779 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2383625 shares
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2625779 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4418250 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.95
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4547371 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
686038 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.81
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P7Y6M3D
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
355404 USD
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5104288 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.80
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodFairValue
0 USD
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y6M18D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4902775 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3096000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.14
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y5M15D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3110775 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3096000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.14
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y5M15D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3110775 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
219868 shares
CY2018Q4 vtnr Warrants Weighted Average Exercise Price Outstanding
WarrantsWeightedAverageExercisePriceOutstanding
3.01
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P0Y11M4D
CY2018Q4 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue
140249 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
1500000 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.25
CY2019 vtnr Granted Weighted Average Remaining Contractual Life In Years
GrantedWeightedAverageRemainingContractualLifeInYears
P9Y8M12D
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedGrantDateFairValue
1496372 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2019 vtnr Warrants Exercised Weighted Average Exercise Price
WarrantsExercisedWeightedAverageExercisePrice
0
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedGrantDateFairValue
0 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
219868 shares
CY2019 vtnr Warrants Cancelledforfeitedexpired Weighted Average Exercise Price
WarrantsCancelledforfeitedexpiredWeightedAverageExercisePrice
3.01
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledGrantDateFairValue
140249 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1500000 shares
CY2019Q4 vtnr Warrants Weighted Average Exercise Price Outstanding
WarrantsWeightedAverageExercisePriceOutstanding
2.25
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P9Y8M12D
CY2019Q4 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue
1496372 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
0 shares
CY2019 vtnr Vested Weighted Average Exercise Price
VestedWeightedAverageExercisePrice
0
CY2019 vtnr Vested Weighted Average Remaining Contractual Life In Years
VestedWeightedAverageRemainingContractualLifeInYears
P0Y
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0 USD
CY2019Q4 vtnr Warrants Exercisable Shares
WarrantsExercisableShares
0 shares
CY2019Q4 vtnr Warrants Exercisable Weighted Average Exercise Price
WarrantsExercisableWeightedAverageExercisePrice
0
CY2019 vtnr Exercisable Weighted Average Remaining Contractual Life In Years
ExercisableWeightedAverageRemainingContractualLifeInYears
P0Y
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableGrantDateFairValue
0 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1500000 shares
CY2019Q4 vtnr Warrants Weighted Average Exercise Price Outstanding
WarrantsWeightedAverageExercisePriceOutstanding
2.25
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P9Y8M12D
CY2019Q4 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue
1496372 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
0 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedGrantDateFairValue
0 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2020 vtnr Warrants Exercised Weighted Average Exercise Price
WarrantsExercisedWeightedAverageExercisePrice
0
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedGrantDateFairValue
0 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
0 shares
CY2020 vtnr Warrants Cancelledforfeitedexpired Weighted Average Exercise Price
WarrantsCancelledforfeitedexpiredWeightedAverageExercisePrice
0
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledGrantDateFairValue
0 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1500000 shares
CY2020Q4 vtnr Warrants Weighted Average Exercise Price Outstanding
WarrantsWeightedAverageExercisePriceOutstanding
2.25
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P8Y8M12D
CY2020Q4 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue
1496372 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
0 shares
CY2020 vtnr Vested Weighted Average Exercise Price
VestedWeightedAverageExercisePrice
0
CY2020 vtnr Vested Weighted Average Remaining Contractual Life In Years
VestedWeightedAverageRemainingContractualLifeInYears
P0Y
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0 USD
CY2020Q4 vtnr Warrants Exercisable Shares
WarrantsExercisableShares
0 shares
CY2020Q4 vtnr Warrants Exercisable Weighted Average Exercise Price
WarrantsExercisableWeightedAverageExercisePrice
0
CY2020 vtnr Exercisable Weighted Average Remaining Contractual Life In Years
ExercisableWeightedAverageRemainingContractualLifeInYears
P0Y
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableGrantDateFairValue
0 USD
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45509470 shares
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30762264 USD
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11445628 USD
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40988946 shares
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30762264 USD
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11445628 USD
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45509470 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40988946 shares
CY2020 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2019 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2020 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2019 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45509470 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40988946 shares
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45554841 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45554841 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43395563 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43395563 shares
CY2020 vtnr Common Stock Voting Rights Numberof Votes
CommonStockVotingRightsNumberofVotes
1 segment
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 vtnr Preferred Stock Amount Received Prior To Similar Liquidation Payments Per Share
PreferredStockAmountReceivedPriorToSimilarLiquidationPaymentsPerShare
1.49
CY2020 vtnr Preferred Stock Conditionsfor Automatic Common Stock Conversion Minimum Gross Public Offering Amount
PreferredStockConditionsforAutomaticCommonStockConversionMinimumGrossPublicOfferingAmount
10000000 USD
CY2020 vtnr Preferred Stock Conditionsfor Automatic Common Stock Conversion Minimum Proceedsto Shareholdersif Companyis Sold Per Share
PreferredStockConditionsforAutomaticCommonStockConversionMinimumProceedstoShareholdersifCompanyisSoldPerShare
10.00
CY2015Q2 vtnr Unit Purchase Agreement Premium Over Closing Stock Price Percentage
UnitPurchaseAgreementPremiumOverClosingStockPricePercentage
0.061
CY2015Q2 vtnr Unit Purchase Agreement Numberof Units Sold
UnitPurchaseAgreementNumberofUnitsSold
8064534 segment
CY2015Q2 vtnr Unit Purchase Agreement Priceper Unit
UnitPurchaseAgreementPriceperUnit
3.10
CY2020Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1 shares
CY2015Q2 us-gaap Share Price
SharePrice
2.91
CY2015Q2 vtnr Proceedsfrom Issuanceof Private Placement Gross
ProceedsfromIssuanceofPrivatePlacementGross
25000000.0 USD
CY2015Q2 vtnr Private Placement Commissions Percentageof Gross Proceeds
PrivatePlacementCommissionsPercentageofGrossProceeds
0.065
CY2015Q2 vtnr Private Placement Amount Raisedfrom Various Investorsfor No Fee
PrivatePlacementAmountRaisedfromVariousInvestorsforNoFee
4000000.0 USD
CY2015Q2 us-gaap Payments For Commissions
PaymentsForCommissions
1400000 USD
CY2015Q2 vtnr Unit Purchase Agreement Liquidated Damages Percentageof Aggregate Subscription Amount
UnitPurchaseAgreementLiquidatedDamagesPercentageofAggregateSubscriptionAmount
0.010
CY2015Q2 vtnr Unit Purchase Agreement Liquidated Damages Percentageof Aggregate Subscription Amount Maximum
UnitPurchaseAgreementLiquidatedDamagesPercentageofAggregateSubscriptionAmountMaximum
0.06
CY2015Q2 vtnr Preferred Stock Termsof Conversion Beneficial Conversion Feature
PreferredStockTermsofConversionBeneficialConversionFeature
5737796 USD
CY2020Q4 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
330412 USD
CY2019Q4 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
1969216 USD
CY2016Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1.56
CY2017Q2 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
1.72
CY2016Q2 vtnr Unit Purchase Agreement Numberof Units Sold
UnitPurchaseAgreementNumberofUnitsSold
12403683 shares
CY2016Q2 vtnr Unit Purchase Agreement Numberof Warrantsper Unit
UnitPurchaseAgreementNumberofWarrantsperUnit
1 segment
CY2016Q2 vtnr Unit Purchase Agreement Priceper Unit
UnitPurchaseAgreementPriceperUnit
1.56
CY2016Q2 vtnr Unit Purchase Agreement Premium Over Closing Stock Price Percentage
UnitPurchaseAgreementPremiumOverClosingStockPricePercentage
0.026
CY2016Q2 us-gaap Share Price
SharePrice
1.52
CY2016Q2 vtnr Proceedsfrom Issuanceof Private Placement Gross
ProceedsfromIssuanceofPrivatePlacementGross
19400000 USD
CY2016Q2 vtnr Private Placement Commissions Percentageof Gross Proceeds
PrivatePlacementCommissionsPercentageofGrossProceeds
0.065
CY2016Q2 us-gaap Payments For Commissions
PaymentsForCommissions
610000 USD
CY2016Q2 vtnr Unit Purchase Agreement Liquidated Damages Percentageof Aggregate Subscription Amount
UnitPurchaseAgreementLiquidatedDamagesPercentageofAggregateSubscriptionAmount
0.010
CY2016Q2 vtnr Unit Purchase Agreement Liquidated Damages Percentageof Aggregate Subscription Amount Maximum
UnitPurchaseAgreementLiquidatedDamagesPercentageofAggregateSubscriptionAmountMaximum
0.06
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1969216 USD
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1481692 USD
CY2020 vtnr Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Changein Valuation
FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityChangeinValuation
-1638804 USD
CY2019 vtnr Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Changein Valuation
FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityChangeinValuation
487524 USD
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
330412 USD
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1969216 USD
CY2020Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-94214 USD
CY2019Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-375850 USD
CY2020 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
3456487 USD
CY2019 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
-2458359 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
135028488 USD
CY2020Q4 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
113766009 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
5090352 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
33315876 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
16172127 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26144264 USD
CY2020Q4 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1895588 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-11867725 USD
CY2020Q4 us-gaap Assets
Assets
122099958 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163365565 USD
CY2019 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
134777113 USD
CY2019 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
5356277 USD
CY2019 us-gaap Gross Profit
GrossProfit
23232175 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24182407 USD
CY2019 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1823812 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-2774044 USD
CY2019Q4 us-gaap Assets
Assets
120759919 USD
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
332497 USD
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
166946 USD
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
91061 USD
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
41889 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
6000000.0 USD
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
6300000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
2300000 USD
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
2300000 USD
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
402560 USD
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
165598 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5614785 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4690619 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4414453 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4360417 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4360417 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
31539490 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
54980181 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
21664305 USD
CY2020 vtnr Lessee Operating Lease Number Of Renewal Options
LesseeOperatingLeaseNumberOfRenewalOptions
2 renewal_option
CY2020 vtnr Agent Term
AgentTerm
P5Y

Files In Submission

Name View Source Status
0001628280-21-004184-index-headers.html Edgar Link pending
0001628280-21-004184-index.html Edgar Link pending
0001628280-21-004184.txt Edgar Link pending
0001628280-21-004184-xbrl.zip Edgar Link pending
a12312020-ex211.htm Edgar Link pending
a12312020-ex231.htm Edgar Link pending
a12312020-ex311.htm Edgar Link pending
a12312020-ex312.htm Edgar Link pending
a12312020-ex321.htm Edgar Link pending
a12312020-ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vtnr-20201231.htm Edgar Link pending
vtnr-20201231.xsd Edgar Link pending
vtnr-20201231_cal.xml Edgar Link unprocessable
vtnr-20201231_def.xml Edgar Link unprocessable
vtnr-20201231_g1.jpg Edgar Link pending
vtnr-20201231_g2.jpg Edgar Link pending
vtnr-20201231_htm.xml Edgar Link completed
vtnr-20201231_lab.xml Edgar Link unprocessable
vtnr-20201231_pre.xml Edgar Link unprocessable